Literature DB >> 17645768

The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses.

R Kingston1, F Burke, J H Robinson, P A Bedford, S M Jones, S C Knight, E D Williamson.   

Abstract

The F1 and V antigens of Yersinia pestis, despite acting as virulence factors secreted by the organism during infection, also combine to produce an effective recombinant vaccine against plague, currently in clinical trial. The protective mechanisms induced by rF1 + rV probably involve interactions with dendritic cells (DC) as antigen uptake, processing and presenting cells. To study such interactions, naive ex vivo DC from bone marrow, spleen and lymph node were cultured with rF1, rV or combined antigens and demonstrated to secrete interleukin (IL)-4 and IL-12 into the culture supernatant. Cytokine production in response to pulsing was dependent on the maturity of the bone marrow-derived DC culture, so that pulsed 8-day-old cultures had accumulated significantly more intracellular IL-4 and IL-12 than unpulsed cells. DC, pulsed with rF1 + rV for 2-24 h, were able to prime naive autologous lymph node T cells to proliferate in an antigen dose-dependent manner, with an order of potency of 3d bone marrow-derived DC (BMDC) > 7d BMDC > splenic DC. Significantly, cell-free supernatants from rF1 + rV-pulsed BMDC and splenic DC were also able to induce specific primary responses effectively in naive T cells, suggesting that these supernatants contained stimulatory factor(s). This study suggests an important role for DC, or factors secreted by them, in the induction of protective immunity to plague by the rF1 and rV antigens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645768      PMCID: PMC2219336          DOI: 10.1111/j.1365-2249.2007.03452.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

Review 1.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

Authors:  P Kaliński; C M Hilkens; E A Wierenga; M L Kapsenberg
Journal:  Immunol Today       Date:  1999-12

2.  MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions.

Authors:  P Bedford; K Garner; S C Knight
Journal:  Int Immunol       Date:  1999-11       Impact factor: 4.823

Review 3.  Plague vaccine research and development.

Authors:  E D Williamson
Journal:  J Appl Microbiol       Date:  2001-10       Impact factor: 3.772

4.  Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid.

Authors:  M B Prentice; K D James; J Parkhill; S G Baker; K Stevens; M N Simmonds; K L Mungall; C Churcher; P C Oyston; R W Titball; B W Wren; J Wain; D Pickard; T T Hien; J J Farrar; G Dougan
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

5.  Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis.

Authors:  M Achtman; K Zurth; G Morelli; G Torrea; A Guiyoule; E Carniel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.

Authors:  Yasemin H K Congleton; Christine R Wulff; Edward J Kerschen; Susan C Straley
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

7.  Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.

Authors:  R P Ciavarra; A R Greene; D R Horeth; K Buhrer; N van Rooijen; B Tedeschi
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

8.  Genome sequence of Yersinia pestis, the causative agent of plague.

Authors:  J Parkhill; B W Wren; N R Thomson; R W Titball; M T Holden; M B Prentice; M Sebaihia; K D James; C Churcher; K L Mungall; S Baker; D Basham; S D Bentley; K Brooks; A M Cerdeño-Tárraga; T Chillingworth; A Cronin; R M Davies; P Davis; G Dougan; T Feltwell; N Hamlin; S Holroyd; K Jagels; A V Karlyshev; S Leather; S Moule; P C Oyston; M Quail; K Rutherford; M Simmonds; J Skelton; K Stevens; S Whitehead; B G Barrell
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  Evaluation of interleukin-4 concentration by ELISA is influenced by the consumption of IL-4 by cultured cells.

Authors:  C Ewen; M E Baca-Estrada
Journal:  J Interferon Cytokine Res       Date:  2001-01       Impact factor: 2.607

10.  Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo.

Authors:  C F d'Ostiani; G Del Sero; A Bacci; C Montagnoli; A Spreca; A Mencacci; P Ricciardi-Castagnoli; L Romani
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  8 in total

1.  Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.

Authors:  Jian Sha; Janice J Endsley; Michelle L Kirtley; Sheri M Foltz; Matthew B Huante; Tatiana E Erova; Elena V Kozlova; Vsevolod L Popov; Linsey A Yeager; Irina V Zudina; Vladimir L Motin; Johnny W Peterson; Kristin L DeBord; Ashok K Chopra
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

2.  Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.

Authors:  Nobuyuki Matoba; Namrata Rahul Shah; Tsafrir S Mor
Journal:  Vaccine       Date:  2011-07-13       Impact factor: 3.641

3.  Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Authors:  Julie A Musson; Rebecca Ingram; Guillaume Durand; Stephanie Ascough; Emma L Waters; M Gillian Hartley; Timothy Robson; Bernard Maillere; E Diane Williamson; Shiranee Sriskandan; Daniel Altmann; John H Robinson
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

Review 4.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

5.  The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague.

Authors:  Florent Sebbane; Clayton Jarrett; Donald Gardner; Daniel Long; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

6.  Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.

Authors:  Karina Ramirez; Alejandra V E Capozzo; Scott A Lloyd; Marcelo B Sztein; James P Nataro; Marcela F Pasetti
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

7.  Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.

Authors:  Wei Li; Shixia Wang; Shan Lu
Journal:  Vaccines (Basel)       Date:  2013-12-27

8.  Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.

Authors:  V A Graham; G J Hatch; K R Bewley; K Steeds; A Lansley; S R Bate; S G P Funnell
Journal:  J Immunol Res       Date:  2014-07-06       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.